Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Crohn's Disease

Interventions

DRUG: NNC 0142-0000-0002
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC